Negative impact on clinical outcome of the mutational co-occurrence of SF3B1 and DNMT3A in refractory anemia with ring sideroblasts (RARS)

Iván MartínDepartment of Hematology, University Hospital La Fe, Valencia, Spain; ;Department of Genomics, University Hospital La Fe, Valencia, Spain; Correspondence[email protected]

Esperanza SuchDepartment of Hematology, University Hospital La Fe, Valencia, Spain;

Blanca NavarroDepartment of Hematology, University Hospital Clinic, Valencia, Spain;

Ana VicenteDepartment of Hematology, Hospital de la Ribera, Alzira, Spain;

María López-PavíaDepartment of Hematology, University Hospital La Fe, Valencia, Spain;

Mariam IbáñezDepartment of Hematology, University Hospital La Fe, Valencia, Spain;

Mar TormoDepartment of Hematology, University Hospital Clinic, Valencia, Spain;

Eva VillamónDepartment of Hematology, University Hospital La Fe, Valencia, Spain;

Inés Gómez-SeguíDepartment of Hematology, University Hospital La Fe, Valencia, Spain;

Irene LunaDepartment of Hematology, University Hospital La Fe, Valencia, Spain;

Silvestre OltraDepartment of Genetics, University Hospital La Fe, Valencia, Spain

Laia PedrolaDepartment of Genomics, University Hospital La Fe, Valencia, Spain;

Miguel Angel SanzDepartment of Hematology, University Hospital La Fe, Valencia, Spain;

Jose CerveraDepartment of Hematology, University Hospital La Fe, Valencia, Spain; ;Department of Genetics, University Hospital La Fe, Valencia, Spain

Guillermo SanzDepartment of Hematology, University Hospital La Fe, Valencia, Spain;

show all

Negative impact on clinical outcome of the mutational co-occurrence of SF3B1 and DNMT3A in refractory anemia with ring sideroblasts (RARS)

ICMJE Form for Disclosure of Potential Conflicts of Interest

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Negative impact on clinical outcome of the mutational co-occurrence of SF3B1 and DNMT3A in refractory anemia with ring sideroblasts (RARS)

ICMJE Form for Disclosure of Potential Conflicts of Interest

Supplemental Material

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date